Working… Menu

BrUOG 355: Nivolumab to Tailored Radiation Therapy With Concomitant Cisplatin in the Treatment of Patients With Cervical Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03527264
Recruitment Status : Active, not recruiting
First Posted : May 17, 2018
Last Update Posted : April 6, 2021
Rhode Island Hospital
The Miriam Hospital
Women and Infants Hospital of Rhode Island
Bristol-Myers Squibb
Information provided by (Responsible Party):
Don Dizon, Brown University

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : December 2021
Estimated Study Completion Date : December 2023